通过Hedyotis扩散型多糖的IL-2/IL-2R通路的激活改善了结直肠癌的免疫疗法
Liangliang Bai1, Xiaoxia Liu2, Ze Yuan2
1School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.
International journal of biological macromolecules
|February 15, 2025
概括
来自Hedyotis diffusa (HDP) 的新型多糖增强了结直肠癌免疫疗法. HDP增强T细胞活性和免疫反应,提高免疫检查点抑制剂的治疗疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大肠直肠癌 (CRC) 对目前的免疫疗法反应有限.
- 新型免疫调节剂对于提高CRC治疗疗效至关重要.
- 散热虫具有已知的免疫调节特性,使其成为发现新药剂的候选人.
研究的目的:
- 为了识别和表征一种来自Hedyotis diffusa (HDP) 的多糖,具有潜在的免疫调节活性.
- 评估HDP与免疫检查点抑制剂 (ICI) 结合用于结直肠癌治疗的疗效.
- 阐明 HDP 增强抗瘤免疫力的机制.
主要方法:
- HDP的识别和特征,它是一种由六个单糖组成的多糖.
- 在小鼠体内研究将HDP与PD-1和CTLA-4抑制剂结合用于治疗CRC.
- 分析瘤微环境中的免疫细胞透 (CD4+,CD8+T细胞) 和效应分子表达.
- 研究由HDP激活IL-2/IL-2R信号通路的情况.
主要成果:
- 当HDP与ICI结合时,在CRC小鼠模型中显著提高了系统免疫力.
- HDP治疗增加了CD4+和CD8+T细胞透到瘤中,并提高了细胞毒性T细胞效应分子的调节.
- 机制研究表明,HDP激活IL-2/IL-2R轴,促进T细胞的增殖.
结论:
- HDP是一种有前途的免疫调节剂,可以增强ICI基础免疫治疗在结肠直肠癌中的疗效.
- HDP通过通过IL-2/IL-2R通路促进T细胞反应而起作用.
- 这项研究为开发HDP作为CRC的新型治疗剂提供了基础.
相关概念视频
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
T Cell Types and Functions
897
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
897
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


